Black Rock Inc. Catalyst Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 18,694,918 shares of CPRX stock, worth $433 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,694,918

Previous 17,732,642 5.43%

Holding current value

$433 Million

Previous $283 Million 2.45%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.68 - $16.92 $14.1 Million - $16.3 Million	962,276 Added 5.43%	18,694,918 $290 Million
Q1 2024 May 10, 2024	BUY	$13.18 - $17.11 $25.2 Million - $32.7 Million	1,910,343 Added 12.07%	17,732,642 $283 Million
Q4 2023 Feb 13, 2024	BUY	$11.78 - $17.29 $5.17 Million - $7.6 Million	439,279 Added 2.86%	15,822,299 $266 Million
Q3 2023 Nov 13, 2023	SELL	$11.69 - $15.02 $5.48 Million - $7.04 Million	-468,842 Reduced 2.96%	15,383,020 $180 Million
Q2 2023 Aug 11, 2023	BUY	$11.5 - $18.08 $5.65 Million - $8.89 Million	491,552 Added 3.2%	15,851,862 $213 Million
Q1 2023 May 12, 2023	SELL	$14.34 - $21.05 $4.73 Million - $6.95 Million	-330,016 Reduced 2.1%	15,360,310 $255 Million
Q4 2022 Feb 13, 2023	BUY	$12.25 - $19.5 $5.16 Million - $8.22 Million	421,395 Added 2.76%	15,690,326 $292 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $58.7 Million - $129 Million	8,317,115 Added 119.64%	15,268,931 $196 Million
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $3.06 Million - $4.21 Million	-490,793 Reduced 6.59%	6,951,816 $48.7 Million
Q1 2022 May 12, 2022	SELL	$5.31 - $8.31 $1.29 Million - $2.01 Million	-242,089 Reduced 3.15%	7,442,609 $61.7 Million
Q4 2021 Feb 10, 2022	SELL	$5.21 - $7.45 $1.45 Million - $2.07 Million	-277,835 Reduced 3.49%	7,684,698 $52 Million
Q3 2021 Nov 09, 2021	SELL	$4.85 - $6.04 $210,024 - $261,556	-43,304 Reduced 0.54%	7,962,533 $42.2 Million
Q2 2021 Aug 11, 2021	BUY	$4.29 - $6.05 $34.3 Million - $48.4 Million	8,005,837 New	8,005,837 $46 Million

Others Institutions Holding CPRX

# of Institutions

394

Shares Held

106M

Call Options Held

164K

Put Options Held

439K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.38B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account